Q Line Biotech Ltd vs Sicagen India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 30, 2026

Key Highlights

The Latest Trading Price of Q-Line Biotech Ltd is ₹ 512.75 as of 30 Oct 15:30 . The P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Sicagen India Ltd changed from 6.7 on March 2023 to 9.4 on March 2026 . This represents a CAGR of 8.83% over 4 years The Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Sicagen India Ltd changed from ₹ 56.98 crore on March 2021 to ₹ 169.28 crore on March 2026 . This represents a CAGR of 19.90% over 6 years The revenue of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 110.94 crore. This represent the decline of -100% The revenue of Sicagen India Ltd for the Jun '26 is ₹ 287.99 crore as compare to the Mar '26 revenue of ₹ 281.02 crore. This represent the growth of 2.48% The ebitda of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 33.57 crore. This represent the decline of -100% The ebitda of Sicagen India Ltd for the Jun '26 is ₹ 14.44 crore as compare to the Mar '26 ebitda of ₹ 14.34 crore. This represent the growth of 0.7% The net profit of Q-Line Biotech Ltd changed from ₹ 17.38 crore to ₹ 0 crore over 3 quarters. This represents a CAGR of -100.00% The net profit of Sicagen India Ltd changed from ₹ 4.8 crore to ₹ 6.93 crore over 9 quarters. This represents a CAGR of 17.73% The Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sicagen India Ltd changed from 40.52 % on March 2021 to 30.65 % on March 2026 . This represents a CAGR of -4.55% over 6 years .

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

About Sicagen India Ltd

Sicagen India Limited, incorporated on June 11, 2004 is India's leading provider of trading and marketing services for construction-related industrial and retail infrastructure.
It operate in a diversified operating segments such as trading of Building materials, Sales & Servicing Power & controls systems , manufacturing of MS barrels and manufacture of water treatment chemicals. The company operates dealership of commercial vehicles for Tata Motors, ranging from the 0.75-ton Tata Ace to Tata Novus, with showrooms in Chennai and Tiruchirapalli, covering 11 districts of Tamil Nadu, India.
In addition, they provides governor services; travel-related and cargo services; and water treatment and process improvement solutions.
Further, the company builds passenger and cargo vessels, boats, tugs, and barges.

FAQs for the comparison of Q-Line Biotech Ltd and Sicagen India Ltd

Which company has a larger market capitalization, Q-Line Biotech Ltd or Sicagen India Ltd?

Market cap of Q-Line Biotech Ltd is 1,196 Cr while Market cap of Sicagen India Ltd is 191 Cr

What are the key factors driving the stock performance of Q-Line Biotech Ltd and Sicagen India Ltd?

The stock performance of Q-Line Biotech Ltd and Sicagen India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Q-Line Biotech Ltd and Sicagen India Ltd?

As of October 30, 2026, the Q-Line Biotech Ltd stock price is INR ₹512.75. On the other hand, Sicagen India Ltd stock price is INR ₹48.5.

How do dividend payouts of Q-Line Biotech Ltd and Sicagen India Ltd compare?

To compare the dividend payouts of Q-Line Biotech Ltd and Sicagen India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.